Post by
retiredcf on Nov 10, 2024 1:15pm
Another View
Funds flow per unit was 26c, beating estimates of 25c; Revenue was inline with estimates at $116.8M. EBITDA of $89.7M beat estimates by 6.3%. Cannacord lowered its target price to $15.50 from $16.00. Funds flow rose 4.1%. NOI rose 3.3%. Net rental income rose 7.1%. Occupancy rose marginally to 95.5%. Nine month payout ratio was 71%. We would consider the results fine. (5iResearch)
Comment by
garyreins on Nov 10, 2024 5:04pm
Its looking like a buy from a trading range/technical perspective between $12.50-$13.00. I have buy orders all the way down to $12.50. If that doesnt hold, help us god. Looks like some big players are shorting CADREITS again and this is volatile